35 studies found for:    " March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting HCV Treatment in HIV Co-Infected Patients in Asia
Conditions: Hepatitis C;   HIV
Intervention: Drug: Pegylated-Interferon and Ribavirin
22 Recruiting Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men
Condition: HIV
Interventions: Behavioral: Gay Poz Sex;   Other: Wait List/Standard of Care
23 Completed Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
24 Unknown  Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo
25 Completed Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Condition: HIV-infection/AIDS
Interventions: Drug: Cenicriviroc;   Drug: Dolutegravir;   Drug: Midazolam
26 Recruiting Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Conditions: Methamphetamine Abuse;   HIV
Interventions: Drug: Extended release naltrexone;   Drug: Placebo
27 Recruiting Enhancing Quality Interventions Promoting Healthy Sexuality
Conditions: Pregnancy in Adolescence;   HIV
Interventions: Behavioral: Making Proud Choices;   Behavioral: Making Proud Choices AND Getting To Outcomes
28 Active, not recruiting A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
Condition: HIV
Intervention: Drug: Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.
29 Completed THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
30 Recruiting Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV+
Intervention:
31 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
32 Completed A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Condition: HIV Infections
Intervention:
33 Active, not recruiting In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
34 Completed Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Condition: HIV Prevention
Interventions: Drug: TFV 1% gel;   Drug: Estradiol vaginal cream
35 Recruiting Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Conditions: Substance-Related Disorders;   Mental Disorders
Intervention: Behavioral: RecoveryTrack - Extended Care (RT-E)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years